[1] Klein C.Genetics in dystonia[J].Parkinsonism Relat Disord,2014,20(1):137-142. [2] Asmus F,Gasser T.Dystonia-plus syndromes[J].Eur J Neurol,2010,17(1):37-45. [3] Lohmann K,Klein C.Genetics of dystonia:what's known? What's new? What's next?[J] Mov Disord,2013,28(7):899-905. [4] 李晓捷,唐久来,马丙祥,等.脑性瘫痪的定义、诊断标准及临床分型[J].中华实用儿科临床杂志,2014,29(19):1520. [5] Cheng FB,Wan XH,Feng JC,et al.Clinical and genetic evaluation of DYT1 and DYT6 primary dystonia in China[J].Eur J Neurol,2011,18(3):497-503. [6] 王琳,万新华,万伏波,等.DYT6型肌张力障碍患者的临床表现和影像学特点[J].中华神经科杂志,2013,46(3):148-152. [7] Kumar KR,Lohmann K,Masuho I,et al.Mutations in GNAL:a novel cause of craniocervical dystonia[J].JAMA Neurol,2014,71(4):490-494. [8] Dobrii V,Kresojevi N,Westenberger A,et al.De novo mutation in the GNAL gene causing seemingly sporadic dystonia in a Serbian patient[J].Mov Disord,2014,29(9):1190-1193. [9] Sun ZF,Zhang YH,Guo JF,et al.Genetic diagnosis of two dopa-responsive dystonia families by exome sequencing[J].PLoS One,2014,9(9):e106388. [10] Lewthwaite AJ,Lambert TD,Rolfe EB,et al.Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease[J].Parkinsonism Relat Disord,2015,21(4):394-397. [11] Mencacci NE,Isaias IU,Reich MM,et al.Parkinson's disease in GTP cyclohydrolase 1 mutation carriers[J].Brain,2014,137(9):2480-2492. [12] Nardocci N.Myoclonus-dystonia syndrome[J].Handb Clin Neurol,2011,100(11):563-575. [13] Korner G,Noain D,Ying M,et al.Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency[J].Brain,2015,138(10):2948-2963. [14] Rose SJ,Yu XY,Heinzer AK,et al.A new knock-in mouse model of I-DOPA-responsive dystonia[J].Brain,2015,138(10):2987-3002. [15] Al-Muslamani AM,Ali F,Mahmood F.A new tyrosine hydroxylase genotype with orofacial dyskinaesia[J].Sultan Qaboos Univ Med J,2014,14(3):397-400. [16] Arrabal L,Teresa L,Sánchez-Alcudia R,et al.Genotype-phenotype correlations in sepiapterin reductase deficiency.A splicing defect accounts for a new phenotypic variant[J].Neurogenetics,2011,12(3):183-191. [17] Lohmann E,Körolu Ç,Hanagasi HA,et al.A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood[J].Parkinsonism Relat Disord,2012,18(2):191-193. [18] Groen JL,Ritz K,Jalalzadeh H,et al.RELN rare variants in myoclonus-dystonia[J].Mov Disord,2015,30(3):415-419. [19] Peall KJ,Kurian MA,Wardle M,et al.SGCE and myoclonus dystonia:motor characteristics,diagnostic criteria and clinical predictors of genotype[J].J Neurol,2014,261(12):2296-2304. [20] Wada T,Takano K,Tsurusaki Y,et al.Japanese familial case of myoclonus-dystonia syndrome with a splicing mutation in SGCE[J].Pediatr Int,2015,57(2):324-326. [21] Drivenes B,Born AP,Ek J,et al.A child with myoclonus-dystonia (DYT11) misdiagnosed as atypical opsoclonus myoclonus syndrome[J].Eur J Paediatr Neurol,2015,19(6):719-721. [22] Peall KJ,Smith DJ,Kurian MA,et al.SGCE mutations cause psychiatric disorders:clinical and genetic characterization[J].Brain,2013,136(1):294-303. [23] Termsarasab P,Yang AC,Frucht SJ.Intermediate phenotypes of ATP1A3 mutations:phenotype-genotype correlations[J].Tremor Other Hyperkinet Mov(NY),2015,16(5):336. [24] Weber A,Kreth J,Müller U.Intronic PRRT2 mutation generates novel splice acceptor site and causes paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) in a three generation family[J].BMC Med Genet,2016,17(1):16-19. [25] Maini I,Iodice A,Spagnoli C,et al.Expanding phenotype of PRRT2 gene mutations:A new case with epilepsy and benign myoclonus of early infancy[J].Eur J Paediatr Neurol,2016,20(3):454-456. [26] Yeh TH,Lin JJ,Lai SC,et al.Familial paroxysmal nonkinesigenic dyskinesia:clinical and genetic analysis of a Taiwanese family[J].J Neurol Sci,2012,323(1/2):80-84. [27] Liang S,Yu X,Zhang S,et al.A case of familial paroxysmal nonkinesigenic dyskinesia due to mutation of the PNKD gene in Chinese Mainland[J].Brain Res,2015,1595:120-126. [28] Tacik P,Loens S,Schrader C,et al.Severe familial paroxysmal exercise-induced dyskinesia[J].J Neurol,2014,261(10):2009-2015. [29] Gardiner AR,Jaffer F,Dale RC,et al.The clinical and genetic heterogeneity of paroxysmal dyskinesias[J].Brain,2015,138(12):3567-3580. [30] Wang HX,Li HF,Liu GL,et al.Mutation analysis of MR-1,SLC2A1,and CLCN1 in 28 PRRT2-negative paroxysmal kinesigenic dyskinesia patients[J].Chin Med J (Engl),2016,129(9):1017-1021. |